Zhitong Finance App News, Zhifei Biotech (300122.SZ) issued an announcement. The company recently learned that the freeze-dried human rabies vaccine (ZFB-3 cells) developed by its wholly-owned subsidiary Anhui Zhifeilong Koma Biopharmaceutical Co., Ltd. (“ZFB-3 cells”) has obtained the China Drug Clinical Trial Approval Notice (Notice Number: 2026LP03473) and agreed to carry out clinical trials to prevent rabies.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.